Grappling with metastatic risk: Bringing molecular imaging of Met expression toward clinical use
- 1 January 2002
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 87 (S39) , 184-193
- https://doi.org/10.1002/jcb.10441
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseProceedings of the National Academy of Sciences, 2002
- Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter FactorMolecular Imaging, 2002
- Gene expression in papillary thyroid carcinoma reveals highly consistent profilesProceedings of the National Academy of Sciences, 2001
- Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsProceedings of the National Academy of Sciences, 2001
- Expression of the hepatocyte growth factor/c‐Met pathway is increased at the cancer front in breast carcinomaPathology International, 2001
- Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cellsOncogene, 2000
- Expression of c-met is a strong independent prognostic factor in breast carcinomaCancer, 1998
- Expression of scatter factor and c‐ met receptor in benign and malignant breast tissueCancer, 1997
- The human met oncogene is related to the tyrosine kinase oncogenesNature, 1985
- Molecular cloning of a new transforming gene from a chemically transformed human cell lineNature, 1984